Company profile

Ticker
LLY
Exchange
Website
CEO
David A. Ricks
Employees
Incorporated
Location
Fiscal year end
Former names
LILLY ELI & CO, LILLY ELI & CO ET AL
SEC CIK
IRS number
350470950

LLY stock data

(
)

Calendar

31 Jul 20
23 Sep 20
31 Dec 20

News

Quarter (USD) Jun 20 Mar 20 Sep 19 Jun 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 19 Dec 18 Dec 17 Dec 16
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code 10b5-1 $Price #Shares $Value #Remaining
8 Sep 20 Melissa S Barnes Common Stock Sell Dispose S Yes 151.01 5,000 755.05K 23,580
1 Sep 20 Michael B Mason Common Stock Payment of exercise Dispose F No 148.39 2,735 405.85K 18,544
1 Sep 20 Michael B Mason Common Stock Option exercise Aquire M No 0 6,244 0 21,279
1 Sep 20 Michael B Mason RSU Common Stock Option exercise Dispose M No 0 6,244 0 0
17 Aug 20 Tai Jackson P Common Stock Grant Aquire A No 151.53 13 1.97K 58,301
17 Aug 20 Fry Stephen F Common Stock Sell Dispose S Yes 150.64 7,204 1.09M 100,211
20 Jul 20 Tai Jackson P Common Stock Grant Aquire A No 167.04 12 2K 58,288
76.6% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1708 1648 +3.6%
Opened positions 168 124 +35.5%
Closed positions 108 114 -5.3%
Increased positions 570 542 +5.2%
Reduced positions 662 654 +1.2%
13F shares
Current Prev Q Change
Total value 944.92B 1.06T -10.5%
Total shares 732.44M 740.48M -1.1%
Total puts 4.39M 4M +9.9%
Total calls 3.83M 3.94M -3.0%
Total put/call ratio 1.1 1.0 +13.3%
Largest owners
Shares Value Change
Lilly Endowment 111.56M $18.32B -1.5%
Vanguard 71.61M $11.76B -1.5%
BLK BlackRock 62.83M $10.32B -2.3%
Primecap Management 39.63M $6.51B -5.5%
STT State Street 36.7M $6.03B -1.0%
FMR 29.99M $4.92B +7.0%
Wellington Management 26.99M $4.43B -25.1%
Capital International Investors 21.18M $3.48B -7.0%
State Farm Mutual Automobile Insurance 18.62M $3.06B 0.0%
JPM JPMorgan Chase & Co. 15.94M $2.62B -8.1%
Largest transactions
Shares Bought/sold Change
Wellington Management 26.99M -9.03M -25.1%
Nuveen Asset Management 8.03M +2.37M +42.0%
Primecap Management 39.63M -2.31M -5.5%
Jennison Associates 8.06M -2.13M -20.9%
N Price T Rowe Associates 6.36M +2.06M +48.1%
FMR 29.99M +1.95M +7.0%
Lilly Endowment 111.56M -1.71M -1.5%
Capital International Investors 21.18M -1.6M -7.0%
BNP Paribas Arbitrage 337.7K -1.56M -82.2%
BLK BlackRock 62.83M -1.47M -2.3%

Financial report summary

?
Management Discussion
  • Management’s discussion and analysis of results of operations and financial condition is intended to assist the reader in understanding and assessing significant changes and trends related to the results of operations and financial position of our consolidated company. This discussion and analysis should be read in conjunction with the consolidated condensed financial statements and accompanying footnotes in Item 1 of Part I of this Quarterly Report on Form 10-Q. Certain statements in this Item 2 of Part I of this Quarterly Report on Form 10-Q constitute forward-looking statements. Various risks and uncertainties, including those discussed in "Forward-Looking Statements" and "Risk Factors" in Part II, Item 1A of this Quarterly Report on Form 10-Q and Item 1A, “Risk Factors,” of Part I of our Annual Report on Form 10-K for the year ended December 31, 2019, may cause our actual results, financial position, and cash generated from operations to differ materially from these forward-looking statements.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: Asian, axial, BePurchased, breast, cert, declared, description, dividend, Donald, Evox, Gemzar, hold, inclusion, Junshi, left, mandated, metastatic, mid, modestly, neurological, Neutralizing, nondeductible, ofPublicly, overturning, payable, resolved, Retevmo, science, Shanghai, SharesPurchased, stage, straight, Tauvid, Undisclosed, verification
Removed: Adcirca, Breakthrough, Evaluation, expiring, hearing, largest, October, offering, prejudice, rapidly, Spain, standard, temporary